Synopsys, Inc.
NasdaqGS-SNPS
Oct '05
Oct '09
Oct '13
Oct '17
Oct '21
LTM
| Income Statement | LTM | Oct '24 | Oct '23 | Oct '22 | Oct '21 | Oct '20 | Oct '19 | Oct '18 | Oct '17 | Oct '16 | Oct '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 6,435.3 | 6,127.4 | 5,318 | 4,615.7 | 4,204.2 | 3,685.3 | 3,360.7 | 3,121.1 | 2,724.9 | 2,422.5 | 2,242.2 |
Total Revenues %Chg | 8% | 15.2% | 15.2% | 9.8% | 14.1% | 9.7% | 7.7% | 14.5% | 12.5% | 8% | 9% |
Cost of Sales | 1,343.9 | 1,245.3 | 1,030.8 | 898 | 861.8 | 794.7 | 752.9 | 735.9 | 654.2 | 543 | 518.9 |
Gross Profit | 5,091.4 | 4,882.1 | 4,287.2 | 3,717.7 | 3,342.4 | 2,890.6 | 2,607.7 | 2,385.2 | 2,070.7 | 1,879.6 | 1,723.3 |
Gross Profit Margin | 79.1% | 79.7% | 80.6% | 80.5% | 79.5% | 78.4% | 77.6% | 76.4% | 76% | 77.6% | 76.9% |
Selling, General & Administrative Expenses | 1,659.1 | 1,427.8 | 1,101.6 | 956.3 | 1,035.5 | 916.5 | 862.1 | 885.5 | 746.1 | 668.3 | 639.5 |
Depreciation & Amortization Expenses | 40.7 | 16.2 | 9.3 | 11.6 | 33.9 | 38.8 | 41.3 | 41.6 | 31.6 | 27.5 | 26 |
Research & Development Expenses | 2,287.3 | 2,082.4 | 1,849.9 | 1,589.8 | 1,504.8 | 1,279 | 1,136.9 | 1,084.8 | 908.8 | 856.7 | 776.2 |
Other Operating Expenses | — | — | 53.1 | 11.2 | 33.4 | 36.1 | 47.2 | 12.9 | 36.6 | 9.6 | 15.1 |
Operating Profit | 1,104.3 | 1,355.7 | 1,273.2 | 1,148.7 | 734.8 | 620.1 | 520.2 | 360.2 | 347.6 | 317.4 | 266.5 |
Operating Margin | 17.2% | 22.1% | 23.9% | 24.9% | 17.5% | 16.8% | 15.5% | 11.5% | 12.8% | 13.1% | 11.9% |
Non-Operating Income | 315.5 | 158.1 | 32.2 | -45.3 | 70.7 | 18 | 25.3 | 3.3 | 35.5 | 12.2 | 15.1 |
Total Non-Operating Income | 315.5 | 158.1 | 32.2 | -45.3 | 70.7 | 18 | 25.3 | 3.3 | 35.5 | 12.2 | 15.1 |
Income Before Provision for Income Taxes | 1,199.5 | 1,513.9 | 1,305.5 | 1,103.5 | 805.5 | 638.2 | 545.5 | 363.5 | 383.1 | 329.5 | 281.6 |
Provision for Income Taxes | 50 | 99.7 | 90.2 | 139.4 | 49.2 | -25.3 | 13.1 | -69 | 246.5 | 62.7 | 55.7 |
Consolidated Net Income | 1,149.5 | 1,414.1 | 1,215.3 | 964.1 | 756.4 | 663.4 | 532.4 | 432.5 | 136.6 | 266.8 | 225.9 |
Net Income Attributable to Minority Interests and Other | 17.2 | 27.6 | 11.8 | 6.2 | 1.2 | 0.9 | — | — | — | — | — |
Net Income Attributable to Discontinued Operations | 830.9 | 821.7 | 2.8 | 14.4 | — | — | — | — | — | — | — |
Net Income Attributable to Common Shareholders | 2,006.5 | 2,263.4 | 1,229.9 | 984.6 | 757.5 | 664.3 | 532.4 | 432.5 | 136.6 | 266.8 | 225.9 |
Basic EPS | 7.5 | 14.8 | 8.1 | 6.4 | 5 | 4.4 | 3.6 | 2.9 | 0.9 | 1.8 | 1.5 |
Diluted EPS | 7.4 | 14.5 | 7.9 | 6.3 | 4.8 | 4.3 | 3.5 | 2.8 | 0.9 | 1.7 | 1.4 |
Basic Weighted Average Shares Outstanding | 155.9 | 153.1 | 152.1 | 153 | 152.7 | 151.1 | 149.9 | 149 | 150.5 | 152 | 155 |
Total Shares Outstanding | 185.7 | 154.1 | 152.1 | 152.4 | 153.1 | 152.6 | 150.3 | 149.3 | 150.4 | 151.5 | 155.2 |
Diluted Weighted Average Shares Outstanding | 157.5 | 155.9 | 155.2 | 156.5 | 157.3 | 155.7 | 154.2 | 153.4 | 154.9 | 154.7 | 158.1 |
EBITDA | 1,591.9 | 1,821.6 | 1,700.3 | 1,539.7 | 1,089.8 | 974.2 | 784.7 | 569.4 | 537 | 524.4 | 478.3 |
Effective Tax Rate | 4.2% | 6.6% | 6.9% | 12.6% | 6.1% | -4% | 2.4% | -19% | 64.4% | 19% | 19.8% |